$CLRB Cellectar Biosciences, Inc. Insider Trading

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

CIK Number: 0001279704
IRS Number: 043321804
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: CLRB
Company Address: 100 CAMPUS DRIVE FLORHAM PARK 07932
Phone number: (608) 441-8120
Former name: COMMON HORIZONS INC, date of change: 2004-02-11
Former name: NOVELOS THERAPEUTICS, INC., date of change: 2005-06-17
Former name: AVAM International, Inc.
Former name: Commons Horizons Inc.

Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124 which could detect tumors and metastases in a broad range of cancers and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was founded in June 1996 and is headquartered in Florham Park, NJ.

Market Capitalization: $9.82M
Prev close: $1.67
Average Daily Volume: 786,032
Days Low: $1.65
Year Low: $1.00
Year High: $6.68

Cellectar Biosciences, Inc. Latest Insider Transactions

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 19 2021	CLRB	Cellectar Bioscien ...	NEIS JOHN	Director	Option Exercise	S	30.40	23,232	706,253	0
Mar 19 2021	CLRB	Cellectar Bioscien ...	NEIS JOHN	Director	Option Exercise	S	30.40	58,640	1,782,656	23,232
Mar 16 2021	CLRB	Cellectar Bioscien ...	NEIS JOHN	Director	Option Exercise	S	30.40	100,515	3,055,656	81,872
Mar 16 2021	CLRB	Cellectar Bioscien ...	NEIS JOHN	Director	Option Exercise	S	30.40	11,200	340,480	182,387
Mar 16 2021	CLRB	Cellectar Bioscien ...	NEIS JOHN	Director	Option Exercise	S	30.40	41,155	1,251,112	193,587
Mar 05 2021	CLRB	Cellectar Bioscien ...	Elefant Dov	Chief Financial Off ...	Option Exercise	A	1.74	430,000	748,200	430,000
Mar 05 2021	CLRB	Cellectar Bioscien ...	Longcor Jarrod	Chief Business Offi ...	Option Exercise	A	1.74	450,000	783,000	450,000
Mar 05 2021	CLRB	Cellectar Bioscien ...	Friend John E. II	Chief Medical Offic ...	Option Exercise	A	1.74	330,000	574,200	330,000
Mar 05 2021	CLRB	Cellectar Bioscien ...	CARUSO JAMES V	President and CEO	Option Exercise	S	30.40	46,948	1,427,219	0
Mar 05 2021	CLRB	Cellectar Bioscien ...	CARUSO JAMES V	President and CEO	Option Exercise	A	1.74	1,600,000	2,784,000	1,600,000
Mar 05 2021	CLRB	Cellectar Bioscien ...	CARUSO JAMES V	President and CEO	Buy	P	1.70	5,100	8,659	86,401	81.3 K to 86.4 K (+6.27 %)
Dec 28 2020	CLRB	Cellectar Bioscien ...	CARUSO JAMES V	President and CEO	Buy	P	1.35	37,037	50,000	81,301	44.3 K to 81.3 K (+83.67 %)
Dec 28 2020	CLRB	Cellectar Bioscien ...	Longcor Jarrod	Chief Business Offi ...	Buy	P	1.35	29,630	40,001	102,148	72.5 K to 102.1 K (+40.86 %)
Dec 28 2020	CLRB	Cellectar Bioscien ...	Elefant Dov	Chief Financial Off ...	Buy	P	1.35	7,407	9,999	11,755	4.3 K to 11.8 K (+170.35 %)
Jul 06 2020	CLRB	Cellectar Bioscien ...	Friend John E. II	VP, Chief Medical O ...	Option Exercise	A	1.34	100,000	134,000	100,000

View all Cellectar Biosciences, Inc. insider transactions.